Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dna.hiva (1 trial)
mva.hiva (1 trial)
ad26.enva.01 vaccine (1 trial)
ad35-env (1 trial)
ad35-grin (1 trial)
ad35 investigational hiv vaccine (1 trial)
bg505 sosip.664 gp140 (1 trial)
HIV Infections (Phase 2)
Trials (4 total)
Trial APIs (7 total)